Introduction: Transcatheter aortic valve implantation (TAVI) although minimally invasive is still accompanied by changes in blood morphological parameters, some of them linked to unfavorable outcomes.

Aim: To find any association between changes in blood morphology reflecting an inflammatory response and acute kidney injury (AKI).

Material And Methods: This study involved 176 consecutive transfemoral TAVI patients with a mean age of 78.4 ±7.0 years. Serum creatinine concentration (CREA) and blood morphology were analyzed in the blood samples taken before the procedure, then approximately 1, 24, 48 and 72 hours after the procedure, and lastly at the time of discharge. Post-procedural maximal or minimal values (max/min) and max/min-to-bs ratio of the laboratory parameters were also calculated.

Results: Leucocyte (WBC) and neutrophil (NEUT) counts increased significantly after the procedure whereas lymphocyte (LYMPH) counts declined markedly, reaching the highest or lowest values 24 hours after the procedure. A significant increase in neutrophil-to-lymphocyte ratio (NLR) was observed. Platelet count (PLT) dropped to a minimum at 72 hours after TAVI but at discharge did not return to the admission level. TAVI was associated with a marked increase in CREA with a peak at 48 hours after the procedure (135.7 ±75.9 μM/l). Patients with AKI ( = 65; 36.9%) presented more pronounced variations in relative changes in counts of all blood morphological parameters. A positive moderate ( = 0.412) correlation between maximal NLR and relative CREA changes was noted.

Conclusions: TAVI is associated with significant changes in blood morphological parameters that reflect an inflammatory response. They are more pronounced among subjects with post-procedural AKI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525280PMC
http://dx.doi.org/10.5114/kitp.2021.109368DOI Listing

Publication Analysis

Top Keywords

blood morphological
16
morphological parameters
16
changes blood
12
hours procedure
12
transcatheter aortic
8
aortic valve
8
valve implantation
8
blood morphology
8
inflammatory response
8
tavi associated
8

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany, Cologne, North-rhine westphalia, Germany.

Background: Alzheimer's disease (AD) presents a prolonged asymptomatic phase, providing a significant timeframe for potential intervention. Leveraging this opportunity necessitates the early identification of diagnostic and prognostic biomarkers to detect Alzheimer's pathology during predementia stages. This enables the identification of individuals likely to progress to Alzheimer's-type dementia, allowing them to benefit from targeted disease-modifying therapies.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

NeuroXT, Seoul, Korea, Republic of (South).

Background: Cerebral microbleeds (CMBs) hold significant clinical relevance, linked to elevated risks of hemorrhages, cognitive decline, and mortality. Notably, with the recent advancement in Alzheimer's treatments, the number of CMBs serves as a crucial safety indicators to assess the risk and occurrence of amyloid-related imaging abnormalities. However, the commonly utilized manual detection process is time-consuming and labor-intensive, prompting the development of various automated detection models.

View Article and Find Full Text PDF

Background: Cerebral amyloid angiopathy (CAA) has been recognized as one of the morphologic hallmarks of Alzheimer disease (AD). The development of new AD drugs has brought unforeseen challenges that manifest as amyloid-related imaging abnormalities (ARIA) appearing as vasogenic edema/effusion (ARIA-E) and cerebral microhemorrhage/hemosiderosis (ARIA-H). The prominence of CAA pathology in aged squirrel monkeys (SQMs), a New World non-human primate model, underlines the importance of advancing this unique species for use in AD and dementia research.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Department of Neurology, University of Cologne, Medical Faculty, Cologne, Germany.

Background: Age represents the predominant risk factor for Alzheimer's disease (AD) dementia. Nevertheless, not every elderly individual undergoes age-related processes that inevitably lead to dementia. The aging process is characterized by cellular senescence, manifesting as morphological changes and the secretion of immune signaling mediators linked to systemic low-grade inflammation.

View Article and Find Full Text PDF

Background: CHRFAM7A is a human-restricted gene associated with neuropsychiatric and neurodegenerative disorders. The translated CHRFAM7A protein incorporates into the α7 nicotinic acetylcholine receptor (α7nAChR) leading to a hypomorphic receptor. Mechanistic insight from isogenic iPSC derived neuronal and mononuclear cells demonstrated that CHRFAM7A affects Ca signaling and activates small GTPase Rac1 leading to an actin cytoskeleton gain of function.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!